Posters

Prevention of postoperative complications in the surgical treatment of cataracts

Poster Details

First Author: N. Aldasheva KAZAKHSTAN

Co Author(s):    G. Zhurgumbayeva   S. Islamova   L. Tashtitova              

Abstract Details

Purpose:

To study the efficacy of non-steroidal anti-inflammatory drugs in the prevention of postoperative complications in the surgical treatment of cataracts.

Setting:

Kazakh Scientific Research Institute of Eye Diseases

Methods:

The study involved 32 patients with an immature senile cataract. Patients were divided into groups: control (18 patients) and main (14 patients) groups. Before the operation, in 1 day, in 1 week and in 1 month after the surgery there were carried out a standard examination and optical OCT. Surgical treatment is phacoemulsification of cataract. All patients in the postoperative period prescribed instillation of combined preparations (dexamethasone + fluoroquinolone antibiotics), the main group of patients in the preoperative period was prescribed additionally Broksinak 2 times a day for 1 day and then in the postoperative period for 2 weeks.

Results:

Indicators of OCT before surgery did not differ in the two groups. The thickness of the retina at the fovea in the main group remained unchanged during the entire period of observation. The control group showed an increase in thickness of the fovea to 1 day after surgery, with subsequent reduction at 1 week and 1 month. Edema in the macula was not clinically significant. Indicators of retinal thickness in perifovea after surgery had a tendency to increase in both groups. The gradient of increase in retinal thickness was consistently higher in all segments of perifovea in the control group.

Conclusions:

Studies have shown that in the postoperative period after uncomplicated phacoemulsification occurs subclinical macular edema, accompanied by a thickening of the retina in the macular area by an average of 3.8% -8.3%. Use of the preparation Broksinak accompanied during phacoemulsification of cataract reduces the gradient of the increase in retinal thickness of 1.5 times, which reduces the risk of developing clinically significant macular edema after surgery.

Financial Disclosure:

NONE